As of 2025-11-18, the Relative Valuation of Creo Medical Group PLC (CREO.L) is 80.42 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 10.25 GBP, the upside of Creo Medical Group PLC based on Relative Valuation is 684.6%.
The range of the Relative Valuation is 68.24 - 111.34 GBP.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 28.5x | 20.2x |
| Forward P/E multiples | 17.5x - 22.4x | 21.0x |
| Fair Price | 68.24 - 111.34 | 80.42 |
| Upside | 565.8% - 986.2% | 684.6% |
| Date | P/E |
| 2025-11-14 | 2.74 |
| 2025-11-13 | 2.76 |
| 2025-11-12 | 2.86 |
| 2025-11-11 | 2.89 |
| 2025-11-10 | 2.90 |
| 2025-11-07 | 2.90 |
| 2025-11-06 | 2.86 |
| 2025-11-05 | 2.76 |
| 2025-11-04 | 2.89 |
| 2025-11-03 | 2.90 |
| 2025-10-31 | 2.90 |
| 2025-10-30 | 2.89 |
| 2025-10-29 | 2.89 |
| 2025-10-28 | 2.89 |
| 2025-10-27 | 2.86 |
| 2025-10-24 | 2.84 |
| 2025-10-23 | 2.82 |
| 2025-10-22 | 2.83 |
| 2025-10-21 | 2.76 |
| 2025-10-20 | 2.75 |
| 2025-10-17 | 2.90 |
| 2025-10-16 | 2.89 |
| 2025-10-15 | 2.86 |
| 2025-10-14 | 2.86 |
| 2025-10-13 | 2.86 |
| 2025-10-10 | 2.90 |
| 2025-10-09 | 2.89 |
| 2025-10-08 | 2.92 |
| 2025-10-07 | 3.02 |
| 2025-10-06 | 3.02 |
| 2025-10-03 | 3.03 |
| 2025-10-02 | 2.98 |
| 2025-10-01 | 3.05 |
| 2025-09-30 | 3.05 |
| 2025-09-29 | 3.15 |
| 2025-09-26 | 3.13 |
| 2025-09-25 | 3.08 |
| 2025-09-24 | 3.15 |
| 2025-09-23 | 3.08 |
| 2025-09-22 | 3.05 |
| 2025-09-19 | 3.13 |
| 2025-09-18 | 3.11 |
| 2025-09-17 | 3.11 |
| 2025-09-16 | 3.12 |
| 2025-09-15 | 3.15 |
| 2025-09-12 | 3.10 |
| 2025-09-11 | 3.21 |
| 2025-09-10 | 3.24 |
| 2025-09-09 | 3.24 |
| 2025-09-08 | 3.32 |